Save time and get answers to complex questions with AI chat
When is tenofovir alafenamide patent expiring?Dabrafenib and trametinib cost?When is the expected fda decision date for apotex's ruxolitinib resubmission?How does iron rich food intake impact lipitor's efficacy?Motegrity ingredients?
See the DrugPatentWatch profile for Alprolix
Alprolix is a brand-name drug for hemophilia B. Here’s a quick overview: - What it is: Eftrenonacog alfa, a recombinant factor IX (FIX)Fc fusion protein. The Fc portion extends the half-life of FIX, so patients don’t need as frequent infusions. - What it’s for: Used to prevent bleeding (prophylaxis) and to treat bleeds in people with congenital factor IX deficiency (hemophilia B). It can also be used for perioperative management. - How it’s given: Intravenous (IV) infusion. Dosing is individualized by a healthcare provider and is often scheduled every 7 to 14 days for prophylaxis, with dosing adjusted based on factor IX levels and bleeding history. On-demand treatment of bleeds is also possible. - Who should use it: Adults and children with hemophilia B who need FIX replacement therapy. - Safety notes: Common side effects include injection-site reactions, headache, and fever. Inhibitors to factor IX can rarely develop, which may reduce effectiveness. Serious allergic reactions or thromboembolic events can occur with improper dosing. Most people need to be monitored by a healthcare provider. - Practical points: Stored refrigerated and infused in a clinical or home setting by someone trained in IV administration after proper instruction. If you’d like, tell me what you want to know next (dosing examples, side effects in more detail, how it compares with other products, or safety monitoring).
Other Questions About Alprolix :